Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD)-Reference-Cited by-同舟云学术

Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD)

Published:2011 Issue:6 Volume:58 Page:475-484
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Han Sang Hoon¹,Zhou Jialun²,Saghayam Suneeta³,Vanar Sasheela⁴,Phanuphak Nittaya⁵,Chen Yi-Ming A⁶,Sirisanthana Thira⁷,Sungkanuparph Somnuek⁸,Lee Christopher KC⁹,Pujari Sanjay¹⁰,Li Patrick CK¹¹,Oka Shinichi¹²,Saphonn Vonthanak¹³,Zhang Fujie¹⁴,Merati Tuti Parwati¹⁵,Law Matthew G²,Choi Jun Yong¹

Affiliation:

1. Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea

2. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia

3. YRG Centre for AIDS Research and Education, Chennai, India

4. Department of Medicine, University of Malaya, Lembah Pantai, Kuala Lumpur, Malaysia

5. Thai Red Cross AIDS Research Centre, Bangkok, Thailand

6. Taipei Veterans General Hospital and AIDS Prevention and Research Centre, National Yang-Ming University, Taipei, Taiwan

7. Research Institute for Health Sciences, Chiang Mai, Thailand

8. Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

9. Hospital Sungai Buloh, Kuala Lumpur, Malaysia

10. Institute of Infectious Diseases, Pune, India

11. Queen Elizabeth Hospital, Hong Kong, China

12. National Center for Global Health and Medicine, Tokyo, Japan

13. National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia

14. Beijing Ditan Hospital, Beijing, China

15. Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/58/6/58_K10E-407/_pdf

Reference33 articles.

1. 1. Carr A, Cooper DA (1998) Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor. N Engl J Med 339: 1296.

2. Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults

3. 3. Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, Ngeth C, Ferradini L, Delfraissy JF, Laureillard D (2008) Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antivir Ther 13: 697-703.

4. 4. Fernandes AP, Sanches RS, Mill J, Lucy D, Palha PF, Dalri MC (2007) Lipodystrophy syndrome associated with antiretroviral therapy in HIV patients: considerations for psychosocial aspects. Rev Lat Am Enfermagem 15: 1041-1045.

5. 5. Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG (2007) Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med 8: 8-16.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression of non-anemic macrocytosis to anemia in HIV-positive persons receiving zidovudine-containing regimens in a resource-limited setting;International Journal of STD & AIDS;2022-10-18

2. Metabolic Consequences of Antiretroviral Therapy;Current HIV/AIDS Reports;2022-03-17

3. Comparative incidence of adverse drug reaction during the first and subsequent year of antiretroviral therapy in a Nigerian HIV infected cohort;African Health Sciences;2021-09-27

4. Managing cardiovascular risk in people living with HIV in Asia – where are we now?;HIV Medicine;2021-09-07

5. HIV and antiretroviral therapy-related fat alterations;Nature Reviews Disease Primers;2020-06-18